This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignee: Shilpa Medicare Limited. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Ratna Phani Ayalasomayajula: Innovator in Medical Formulations
Introduction
Ratna Phani Ayalasomayajula is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of medical formulations, holding a total of 4 patents. His work focuses on innovative solutions that address critical healthcare needs.
Latest Patents
One of his latest patents is a tranexamic acid spray for knee arthroplasty. This invention relates to novel formulations comprising a sprayable composition that includes tranexamic acid and chitosan. It is designed for use in the treatment of wounds or injuries, particularly as a topical hemostatic composition for surgical interventions. Another notable patent is for ophthalmic compositions of cyclosporine. This invention includes an ophthalmic composition comprising from about 0.03% to about 2% by weight of cyclosporine and from about 0.05% to about 5% by weight of tamarind seed polysaccharide, along with a pharmaceutically acceptable carrier. It also details the process for preparing these compositions and their application in treating dry eye.
Career Highlights
Ratna Phani Ayalasomayajula is associated with Shilpa Medicare Limited, where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in developing formulations that enhance patient care and treatment outcomes.
Collaborations
He has collaborated with notable colleagues, including Gunneswara Subramanya Vara Prasad Rangabhatla and Vara Prasad Rangabhatla Gunneswara Subramanya, contributing to a dynamic research environment.
Conclusion
Ratna Phani Ayalasomayajula's contributions to medical formulations exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving treatment options for patients, showcasing the importance of research and development in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile